TruScreen Group Limited (ASX:TRU) is celebrating news that it has been included in the Vietnamese Ministry Of Health (MOH) approved Technical List.
CEO Dr Beata Edling said this significant milestone enables TruScreen to be used nationally from top level hospitals to community health centres. The listing reduces the need for individual hospitals to seek prior approval thereby shortening dramatically the procurement process.
The MOH recognised the value of the Truescreen technology in accelerating the cervical cancer screening at lower public healthcare costs with greater innovative patient-focused approach. The listing by the MOH was based on extensive clinical evidence supporting TruScreen, positive feedback from local users at several levels of the public healthcare providers, including leading gynaecological hospital, Hanoi Obstetrics and Gynaecology Hospital.
The Inclusion in the approved Technical List will allow our distributor Gorton Health Services (GHS) to expand distribution of the TruScreen AI-enable technology in Vietnam.
“We are delighted that the Ministry of Health in Vietnam has approved TruScreen as the technology that will assist Vietnam in achieving the World Health Organisation targets in cervical cancer screening,” Edling said.
“The work of our partner in Vietnam, GHS, has prepared Truscreen for an accelerated national uptake. We congratulate GHS on their efforts and look forward to this new phase of growth development.”
